Metabolic and inflammatory links between metabolic dysfunction-associated steatotic liver disease and Alzheimer's disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) and Alzheimer’s disease (AD) are two growing epidemics across the globe. The two chronic, complex diseases have been increasingly linked through shared metabolic, inflammatory, and molecular pathways. Like many other complex diseases,...
Saved in:
| Main Author: | Gary Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Environmental Disease |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/ed.ed_5_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01) -
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01) -
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01) -
Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01) -
Association of the dietary index for gut microbiota and dietary inflammation index with metabolic dysfunction-associated steatotic liver disease and metabolic alcohol-associated liver disease
by: Wenhao Wu, et al.
Published: (2025-07-01)